IASR Vol.41, No. 9 (No.487), September 2020 Rubella and congenital rubella syndrome in Japan as at July 2020

IASR Vol. 41,
No.9 (No. 487) September 2020

Future actions on the elimination of rubella, with FY2020 set as the target year
Response to a rubella outbreak at a host club located in an entertainment district, Tokyo
Response to a rubella outbreak at a Japanese language school, Nagoya City
Characteristics of 5 congenital rubella syndrome patients born in January 2019 – June 2020, Japan
Survey on the implementation status of rubella virus genetic tests at local public health institutes, Japan
External quality assessment operations, Japan (for measles and rubella tests)
Rubella vaccination status and seroprevalence in Japan, FY2019―National Epidemiological Surveillance of Vaccine-Preventable Diseases (provisional results)
Immunization status for measles and rubella (MR) combined vaccine among children during the COVID-19 pandemic, Japan
Global situation of rubella and congenital rubella syndrome
Results from the active epidemiological investigation on COVID-19, Japan (First report) (as at 3 June 2020, provisional)
Detection of Baloxavir-resistant PA E23K-mutated influenza virus from Baloxavir-untreated patients, Japan
Outbreak of parainfluenza virus in a ward for individuals with severe motor and intellectual disabilities, Toyama City
Evaluation of infectivity based on isolation of SARS-CoV-2 from COVID-19 patients, Hiroshima City
Characteristics of household transmission of SARS-CoV-2, Okinawa Prefecture